Neumora Therapeutics, Inc.

Historical 13F Holders

Symbol
NMRA
CUSIP
640979100
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 640979100 since 12/18/2024, largest first.

Filer % of Class Filed
ARCH Venture Fund XII, L.P. 13D/A
18.7% 4/1/2026
Event 3/30/2026
Paul L Berns 13G/A 5.4% 11/16/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Invus Global Management, LLC 13G/A
4.7% 5/4/2026
Event 3/31/2026
K2 HealthVentures Equity Trust LLC 13G/A
3.1% 5/15/2026
Event 3/31/2026
FMR LLC 13G/A
2.2% 5/12/2025
Event 3/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 128 117 M $69.7M
2026 Q2 116 80.3 M $136M
2026 Q1 116 74.6 M $145M
2025 Q4 104 67.2 M $120M
2025 Q3 98 54.9 M $99.9M
2025 Q2 102 60.3 M $44.2M
2025 Q1 121 69.5 M $69.5M
2024 Q4 148 84.5 M $896M
2024 Q3 110 72.9 M $962M
2024 Q2 96 68.0 M $669M
2024 Q1 90 56.9 M $783M
2023 Q4 62 48.0 M $817M
2023 Q3 40 40.6 M $572M